Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

By Sriparna Roy and Abigail Summerville (Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect ...

Kenvue (KVUE +1%) is ticking higher following a flurry of announcements this morning. The company, which provides consumer health products across self-care and essential health categories (Tylenol, ...

Musk has signaled that Tesla investors could vote on whether to invest in xAI at the upcoming shareholder meeting. Kenvue (KVUE) CEO is stepping down as pressure from activist investors intensifies.

NEW YORK/FRANKFURT (Reuters) -Activist shareholders are poised to push harder for corporate changes in the coming months, finding fresh confidence to launch campaigns as the pace of dealmaking ...

Activist shareholders are poised to push harder for corporate changes in the coming months, finding fresh confidence to launch campaigns as the pace of dealmaking picks up again.

Activist investors who push companies for operational changes and management shake-ups waged fewer campaigns during the first half of 2025 as tariffs, wars and U.S. President Donald Trump's ...

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena ...